Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CMOC Group Limited Capital/Financing Update 2022

May 26, 2022

50942_rns_2022-05-26_0685c32c-336d-4532-9e6d-a0d2df8cbf75.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [452 x 110] intentionally omitted <==

(Stock Code: 03993)

RESULTS OF THE ISSUANCE OF THE 2022 FOURTH TRANCHE SUPER SHORT-TERM FINANCING INSTRUMENTS

This announcement is made by China Molybdenum Co., Ltd. (the “ Company ”) pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules* ”) and Inside Information Provisions (as defined under the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong).

We refer to the announcement of the Company dated 29 January 2021 and the circular of the Company dated 20 April 2021 in relation to, among other things, the proposed issuance of debt financing instruments.

I. REGISTRATION OF THE SUPER SHORT-TERM FINANCING INSTRUMENTS

In accordance with the notice of acceptance of registration issued on 6 August 2021 (Zhong Shi Xie Zhu [2021] SCP No. 316) (the “ Notice ”) from the National Association of Financial Market Institutional Investors (the “ Association ”), the Association accepted the registration of the Company’s super short-term financing instruments. Pursuant to the Notice, the registration of the Company’s super short-term financing instruments in a principal amount of RMB6 billion will be valid for a period of two years from the issuance date of the Notice (namely 6 August 2021). The Company may issue the super short-term financing instruments in tranches during the effective period of registration, and shall file with the Association before making any issuance which is required to be filed after the registration. Upon completion of the issuance, the results of issuance shall be disclosed through channels recognized by the Association.

– 1 –

II. ISSUANCE OF THE SUPER SHORT-TERM FINANCING INSTRUMENTS

In accordance with the Notice, the Company successfully issued the 2022 fourth tranche of super short-term financing instruments. The issuance results are as follows:

Particulars of the issuance
Name China
Molybdenum
Co., Ltd. 2022
fourth tranche
super short-
term financing
instruments
Abbreviation 22 CMOC
SCP004
Code 012281924 Term 30 days
Interest
commencement
date
26 May 2022 Payment date 25 June 2022
Total amount
of the proposed
issuance
RMB1 billion Total amount of
actual issuance
RMB1 billion
Coupon 2.10% Issue price RMB100 per note
(RMB100 face
value)
Application for subscription
Number of
qualified
applicants for
subscription
10 units Qualified
subscription
amount
RMB1.16 billion
Highest
subscription price
2.30% Lowest
subscription price
2.00%
Number of valid
subscription
applicants
8 units Amount of valid
subscription
RMB1.01 billion
Bookrunner China Minsheng Banking Corp., Ltd.
Lead underwriter China Minsheng Banking Corp., Ltd.
Joint Lead Underwriter Ping An Bank Co., Ltd.

– 2 –

The Company will make further announcement(s) to keep shareholders and prospective investors informed of the progress of the issuance of the super shortterm financing instruments.

By Order of the Board China Molybdenum Co., Ltd.* Yuan Honglin Chairman

Luoyang City, Henan Province, the PRC, 26 May 2022

As at the date of this announcement, the Company’s executive directors are Mr. Sun Ruiwen and Mr. Li Chaochun; the Company’s non-executive directors are Mr. Yuan Honglin, Mr. Guo Yimin and Mr. Cheng Yunlei; and the Company’s independent nonexecutive directors are Mr. Wang Gerry Yougui, Ms. Yan Ye and Mr. Li Shuhua.

  • For identification purposes only

– 3 –